AUREST

Engineering the future of medicine.

Advanced biotechnology for the moments when medicine has seconds to act.

Medicine needsmore time.

When seconds decide survival, biology has to move faster. Aurest builds biotechnology for those critical moments.

Red blood cells trapped in a tight biopolymer fibrin clot mesh01

STOP

Next-generation hemostatic technologies.

Disarming lethal venom toxins directly at the bite site02

NEUTRALIZE

Disarming lethal venom toxins directly at the bite site.

Vitrification platforms that protect biologics without cold chain03

PRESERVE

Vitrification platforms that protect biologics without cold chain.

About Aurest

Science that reaches the patient.

A deep-tech biotechnology company. We don't just publish papers. We build real products that save real lives.

People still die from problems science already understands.

Trauma

Someone bleeds out on a highway because help arrived too late.

Snakebite

A farmer collapses in a field because antivenom is three hours away.

Blood shortage

A crash victim dies in shock because donor blood cannot survive without a fridge.

Organ failure

A patient dies on a hospital waiting list because a donor organ never came.

Cold chain

A life-saving medicine fails because tropical heat destroyed it before reaching the village.

The knowledge exists. What's missing are products that are fast, simple and affordable enough to reach everyone.

That is the gap Aurest is here to fill.

01

Acute trauma & hemostasis

Halting catastrophic arterial hemorrhage and traumatic shock on highways, battlefields, and surgical suites.

02

Venom neutralization

Universal, pre-hospital countermeasures engineered to disarm lethal venom enzymes directly at the bite site without refrigeration.

03

Cold-chain elimination

Biopolymer vitrification matrices that keep fragile biologics, vaccines, and insulin stable in high temperatures.

Our Technology

Three technologies.One mission: keep people alive.

Designed and developed in our own laboratory. Each one targets a moment where today's medicine falls short.

Patent pending

V Seal

Stops the bleed. Seals the vessel.

The problem
Uncontrolled arterial bleeding kills within minutes. Traditional dressings merely soak up blood and wait for slow, passive clotting that often arrives too late.
Our approach
V Seal is an active biopolymer matrix that forms instant covalent tissue bonds and triggers accelerated clot formation.
  • Arrests catastrophic arterial and venous hemorrhage.
  • Functions independently of the patient's natural coagulation cascade.
  • Field-ready for combat medics, first responders, and trauma surgeons.
Used in
  • Road accidents
  • Battlefield trauma
  • Emergency surgery
  • First responder kits

Indian Patent Application No. 202611070798

Our Vision

This is just the beginning.

Our three core technologies are Phase One. Here's where we're heading next, with biological moonshots we're committed to for decades.

01

Haemodust

Natural donor blood spoils in 42 days, requires cold-chain refrigeration, and demands strict blood-type matching—making it completely unavailable in rural crashes, ambulances, and remote combat zones.

'Blood in a packet': a room-temperature dry powder that reconstitutes into an oxygen-carrying volume expander in 3 seconds when mixed with clean saline.

Shelf Life
35 to 42 days5+ Years
Storage
2°C–8°C FridgeRoom Temp (-40°C to +55°C)
Compatibility
Type matching requiredUniversal for anyone
Goal

Oxygen-carrying resuscitation in every ambulance, military combat kit, and rural health center.

02

Organ Bioprinting

Millions of patients die worldwide on waiting lists for donor organs that never arrive, while toxic lifelong immunosuppressants slowly destroy healthy tissue.

3D bioprinting living, vascularized organs directly from the patient's own reprogrammed cells—zero donors, zero waiting lists, and zero immune rejection.

  1. Vascularized skin
  2. Cartilage & bone
  3. Microvessels
  4. Complex whole organs
Goal

On-demand organ replacement manufactured indigenously at a fraction of global transplant costs.

03

Artificial Thymus Matrix

Autoimmune diseases force millions onto lifelong toxic immunosuppressants that shut down the entire immune system just to slow down rogue self-attacking T-cells.

An implantable 3D biopolymer sponge that lures attacking T-cells in-vivo, transfects them with FOXP3 mRNA, and re-educates them into permanent peacekeeper regulatory T-cells.

  1. Chemokine lure
  2. FOXP3 transfection
  3. Epigenetic lock
  4. Organ protection
Goal

Permanent remission of autoimmune disease without suppressing the immune system.

Widen the window in which a life can be saved.

Portrait of Priyanshu Sharma
18Age he founded Aurest
2Patent applications filed
MNITResearch base, Jaipur

Founder

Priyanshu Sharma

Founder & CEO, Aurest Biotech

Priyanshu Sharma started Aurest Biotech at 18, while most people his age were still choosing a college.

It began with one question he couldn't let go of: why do people still die from problems that science already understands?

There was no shortcut. He taught himself molecular biology, biochemistry and biomedical engineering by reading research papers and spending long hours in the lab, running experiments, failing, adjusting and trying again.

Today he has invented Aurest's core technologies, filed two patent applications in his own name, built working prototypes and set up a registered company. He leads Aurest's research from the MNIT Innovation and Incubation Centre in Jaipur.

“I am not here to participate in the future of world biotech. I am here to build it.”
Priyanshu Sharma

Our Ecosystem

Backed by India's leading innovation institutions.

MNIT Innovation and Incubation Centre (MIIC)

Malaviya National Institute of Technology, Jaipur

A leading deep-tech incubator at one of India's top NITs. Aurest runs its core lab research here, with modern lab facilities and guidance from experienced academic and industry mentors.

Visit website

Atal Incubation Centre (AIC MUJ)

Manipal University Jaipur, supported by Atal Innovation Mission, NITI Aayog

The Government of India's flagship programme for innovation and startups. Its incubation centres support deep-tech companies with mentorship, funding access and national networks.

Visit website

Contact

Let's build something that matters.

The future of medicine will be written in biology, and India can lead it. We're looking for people who want to be part of that.

Who are you?

If you believe in what we're building, let's talk.